Urgent.News

What's breaking now, across thousands of outlets.

More in Health & Medicine

Daewoong Secures U.S. Patent for Ionizable Lipid

Daewoong Pharmaceutical said on Aug. 27 that the U.S. Patent and Trademark Office (USPTO) had notified the company of its decision to grant a patent for ionizable lipid-related technology, a core…

  • Daewoong Pharmaceutical receives USPTO confirmation for ionizable lipid patent on August 27.
  • Patent covers ionizable lipid structures in eTurna LNP delivery platform.
  • Acquisition of Turn Biotechnologies assets strengthens Daewoong's mRNA therapeutics position.

More from Thursday 27 August →